Rodryg Ramlau

kewarganegaraan: Polandia

bahasa ibu: Polandia

bahasa tutur atau tulis: Polandia

pendidikan: Poznań University of Medical Sciences

pekerjaan: peneliti, dokter, oncologist

Seri

There is nothing here

Create a new serie

Karya

There is nothing here

Create a new work

Artikel 106

Date

Judul

Pengarang

2020-05-04

PD-1 Blockade in Anaplastic Thyroid Carcinoma

Armando Santoro, Paolo Antonio Ascierto, Rodryg Ramlau, Hans Gelderblom
2020-06-26

A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer: Protocol-Specified Final Analysis of KEYNOTE-407

Rodryg Ramlau
2020-01-01

Effectiveness of osimertinib in patients with lung adenocarcinoma in clinical practice - the Expanded Drug Access Program in Poland

Magdalena Knetki-Wróblewska, Rafal Dziadziuszko, Maciej Krzakowski, Rodryg Ramlau, Janusz Milanowski, Maciej Bryl, Robert Kieszko
2020-08-01

Lung Cancer in Poland

Rafal Dziadziuszko, Maciej Krzakowski, Rodryg Ramlau, Katarzyna Dziadziuszko, Jacek Jassem, Joanna Chorostowska-Wynimko, Wojciech Biernat, Tomasz Grodzki, Joanna Didkowska, Jacek Niklinski, Renata Langfort
2019-03-01

Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study

Bartosz Kubisa, Rodryg Ramlau
2019-11-03

Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma

Rodryg Ramlau, Kamila Wojas-Krawczyk, Janusz Milanowski, Marcin Nicos, Robert Kieszko
2019-11-21

Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer

Rodryg Ramlau
2019-12-12

Randomized Phase III Study of Ganetespib, a Heat Shock Protein 90 Inhibitor, With Docetaxel Versus Docetaxel in Advanced Non-Small-Cell Lung Cancer (GALAXY-2)

Rodryg Ramlau
2019-02-26

Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis - A multicentre study

Rodryg Ramlau, Robert Jach, Ewa Nowak-Markwitz, Anita Olejek, Anita Chudecka-Głaz, Janina Markowska, Pawel Knapp, Violetta Filas, Stefan Sajdak, Wiesława Bednarek
2019-01

Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P-gp Substrates in Patients With an Advanced Solid Tumor

Rodryg Ramlau
2019-10-18

Changes in central and peripheral blood pressure parameters during antiangiogenic treatment of metastatic renal cell carcinoma

Rodryg Ramlau, Andrzej Tykarski, Paweł Uruski
2019-10-15

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial

Rafal Dziadziuszko, Maciej Krzakowski, Rodryg Ramlau, Jan Van Meerbeeck
2018-08-23

Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer

Brian Schwartz, Sergey Orlov, Rodryg Ramlau
2018-02-09

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous no

Rodryg Ramlau, Cesare Gridelli
2018-08

Discrepancies between ALK protein disruption and occurrence of gene rearrangement in Polish NSCLC patients

Rodryg Ramlau, Tomasz Grodzki, Kamila Wojas-Krawczyk, Halina Batura-Gabryel, Aleksandra Szczesna, Janusz Milanowski, Marcin Nicos, Bożena Jarosz, Maciej Bryl, Justyna Szumiło
2018-06-25

Current views on molecularly targeted therapy for lung cancer - a review of literature from the last five years

Rodryg Ramlau
2017-05-10

A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer

Sergey Orlov, Rodryg Ramlau
2017-04-03

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations

Paweł Krawczyk, Dariusz M Kowalski, Rodryg Ramlau, Ewa Kalinka-Warzocha, Kinga Winiarczyk, Katarzyna Stencel, Tomasz Powrózek, Kamila Wojas-Krawczyk, Magdalena Wójcik-Superczyńska, Maciej Glogowski, Maciej Krzakowski, Janusz Milanowski, Maciej Bryl
2017-06-21

Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project

Angelika Edyta Charkiewicz, Anetta Sulewska, Magdalena Niemira, Lukasz Minarowski, Wojciech Naumnik, Michal Ciborowski, Marcin Moniuszko, Monika Kaczmarek, Ewa Sierko, Robert Mroz, Jacek Szamatowicz, Joanna Reszeć-Giełażyn, Rodryg Ramlau, Zenon Mariak, Barbara Mroczko, Andrzej Ciereszko, Adam Krętowski, Jolanta Małyszko, Jacek Niklinski, Cezary Piwkowski, Radoslaw Charkiewicz, Anna Michalska-Falkowska, Paweł Kurzawa
2017-09-07

Predictors of EGFR mutation and factors associated with clinical tumor stage at diagnosis: Experience of the INSIGHT study in Poland

Rodryg Ramlau, Paweł Krawczyk, Rafal Dziadziuszko, Izabela Chmielewska, Katarzyna Stencel, Agnieszka Segiet, Joanna Chorostowska-Wynimko, Michał Skroński, Janusz Milanowski
2017-10-13

Efficacy and Safety of Necitumumab Continuation Therapy in the Phase III SQUIRE Study of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.

Tudor Ciuleanu, Rodryg Ramlau, Aleksandra Szczesna
2017-03-02

An Open-Label, Randomized, Controlled Phase II Study of Paclitaxel-Carboplatin Chemotherapy With Necitumumab Versus Paclitaxel-Carboplatin Alone in First-Line Treatment of Patients With Stage IV Squamous Non-Small-Cell Lung Cancer.

Rodryg Ramlau
2017-02-10

Venous thromboembolism prophylaxis in cancer patients — guidelines focus on surgical patients

Maciej Kostrubiec, Stefan Sajdak, Janina Markowska, Rodryg Ramlau, Piotr Rutkowski, Wojciech Dyszkiewicz, Tomasz Urbanek, Piotr Jan Wysocki, Piotr Ładziński, Artur A Antoniewicz, Jan Kulig, Krzysztof Ziaja
2016-03-12

The Effect of Necitumumab in Combination with Gemcitabine plus Cisplatin on Tolerability and on Quality of Life: Results from the Phase 3 SQUIRE Trial

Rodryg Ramlau, György Losonczy, Aleksandra Szczesna
2016-12-04

The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients

Slawomir Michalak, Joanna Rybacka-Mossakowska, Rodryg Ramlau, Wojciech Ambrosius
2016-01-01

Humoral Immune Response against Neural Antigens and Its Effects on Cognition in Lung Cancer Patients

Rodryg Ramlau
2016-03-18

The Effect on Cognition of Mitochondrial Respiratory System Proteins in Peripheral Blood Mononuclear Cells in the Course of Lung Cancer.

Rodryg Ramlau
2015-09-28

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies

Małgorzata Wierzbicka, Piotr Milecki, Rodryg Ramlau, Krzysztof Szyfter
2015-08-16

The Effectiveness of Pemetrexed Monotherapy Depending on Polymorphisms in TS and MTHFR Genes as Well as Clinical Factors in Advanced NSCLC Patients

Tomasz Kucharczyk, Paweł Krawczyk, Tomasz Powrózek, Dariusz M Kowalski, Rodryg Ramlau, Ewa Kalinka-Warzocha, Magdalena Knetki-Wróblewska, Kinga Winiarczyk, Maciej Krzakowski, Janusz Milanowski
2015-02-18

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Mariano Provencio, Rodryg Ramlau, György Losonczy, Aleksandra Szczesna
2015-01-20

Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non-Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker

Rodryg Ramlau, Michael Thomas
2015-08-14

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

Giuseppe Giaccone, Rodryg Ramlau

Human - wd:Q53373129

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut